Bei der Therapie des Diabetes mellitus im höheren Lebensalter müssen verschiedene Aspekte berücksichtigt werden, z. B. die körperliche und geistige Konstitution des Patienten. Der Beitrag beleuchtet die für den Hausarzt und Internisten wesentlichen Punkte, schwerpunktmäßig beim Typ-2-Diabetes.
Literatur
Rathmann W, Haastert B, Icks A et al. Prevalence of the metabolic syndrome in the elderly populati9on according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care 2000; 29:461
diabetesDE (Hrsg) Deutscher Gesundheitsbericht Diabetes 2010. Kirchheim-Verlag, 2009.
Scherbaum WA. Individualisierte Medizin in der Diabetologie. Der Diabetologe 2012; 8:94–97.
Wernecke J, Bahrmann A, Zeyfang A. Individuelle Therapieziele bei betagten Diabetespatienten. Der Diabetologe 2012; 8:108–112.
Tseng CL, Soroka O, Maney M et al. Assessing potential glycaemic overtreatment in persons at hypoglycaemic risk. JAMA intern Med 2014; 174:259–268.
Sinclair A et al. Diabetes mellitus in older people. Position Statement on behalf of the InternationalAssociation of Gerontologyand Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Tast Force of Experts inDiabetes. JAMDA 2012; 13:497–502.
Currie CJ, Peters JR, Tynan A et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010; 375:481–489.
Abholz HH, Egedi C, Gries FA et al. Nationale Versorgungsleitline Therapie des Typ-2-Diabetes (Teil 2). Diabetologie 2014; 9:241–299.
Inzucchi SE, Bergensthal RM, Buse JB et al.: Management of hyperglycaemia in Type 2 diabetes, 2015: A patient-centered approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. doi: 10.2337/dc14-2441 Diabetes Care January 2015 vol. 38 no. 1, 140–149.
Scirica BM, Bhatt DL, Braunwald E. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. NEJM 2013; 369:1317–1326.
White WB, Cannon CP, Heller SR et al. Alogliptin after acutecoronary syndrome in patients with type 2 diabetes. NEJM 2013; 369:1327–1335.
Selvin E, Bolen S, Yeh HC et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008; 168:2070–2080.
Siegmund T, Schumm-Draeger PM. Therapie mit oralen Antidiabetika und/oder Insulin im höheren Alter? Der Diabetologe 2010; 6:560–569.
American Diabetes Association. Approaches to Glycemic Treatment. Pharmacological Therapy for Type 1 Diabetes and for Type 2 Diabetes. doi: 10.2337/dc15-S010 Diabetes Care January 2015 vol.38 no. Supplement 1, S41-S48.
The DECODE Study Group. Age and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26:61-69.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scherbaum, W.A. Tipps für die Behandlung älterer Diabetiker. MMW - Fortschritte der Medizin 157, 39–43 (2015). https://doi.org/10.1007/s15006-015-3030-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-015-3030-5